These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25902327)

  • 21. Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial.
    Adnan N; Boland F; Murphy DJ
    Trials; 2017 Nov; 18(1):541. PubMed ID: 29141679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxytocin infusion rates for maintaining uterine tone during non-elective cesarean section in laboring patients: a randomized, controlled trial.
    Mohta M; Siddiqui S; Chilkoti GT; Agarwal R
    J Anesth; 2022 Aug; 36(4):456-463. PubMed ID: 35484429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands.
    Holleboom CA; van Eyck J; Koenen SV; Kreuwel IA; Bergwerff F; Creutzberg EC; Bruinse HW
    Arch Gynecol Obstet; 2013 Jun; 287(6):1111-7. PubMed ID: 23329341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weight-based oxytocin infusion for preventing uterine atony during caesarean delivery in non-labouring patients: A dose-response study.
    Tyagi S; Tyagi A; Rashmi S; Mohta M; Gupta B
    Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):497-503. PubMed ID: 36846888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.
    Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ
    Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis.
    Phung LC; Farrington EK; Connolly M; Wilson AN; Carvalho B; Homer CSE; Vogel JP
    Am J Obstet Gynecol; 2021 Sep; 225(3):250.e1-250.e38. PubMed ID: 33957113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic Administration of Uterotonics to Prevent Postpartum Hemorrhage in Women Undergoing Cesarean Delivery for Arrest of Labor: A Randomized Controlled Trial.
    Balki M; Downey K; Walker A; Seaward G; Carvalho JCA
    Obstet Gynecol; 2021 Mar; 137(3):505-513. PubMed ID: 33543897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Prophylactic Oxytocin in the Third Stage of Labor: Physiologic Versus Pharmacologically Influenced Labor and Birth.
    Erickson EN; Lee CS; Emeis CL
    J Midwifery Womens Health; 2017 Jul; 62(4):418-424. PubMed ID: 28703925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbetocin at elective Cesarean delivery: a sequential allocation trial to determine the minimum effective dose.
    Khan M; Balki M; Ahmed I; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2014 Mar; 61(3):242-8. PubMed ID: 24281981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial.
    Charles D; Anger H; Dabash R; Darwish E; Ramadan MC; Mansy A; Salem Y; Dzuba IG; Byrne ME; Breebaart M; Winikoff B
    BMC Pregnancy Childbirth; 2019 Jan; 19(1):38. PubMed ID: 30658605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial.
    Davies GA; Tessier JL; Woodman MC; Lipson A; Hahn PM
    Obstet Gynecol; 2005 Feb; 105(2):294-9. PubMed ID: 15684155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Intraoperative Median Effective Dose of Oxytocin for Preventing Uterine Atony in Parturients with a Prior History of Caesarean Delivery.
    Wei CN; Drzymalski D; Cao YF; Ping ZP; Wu H; Chen XZ
    Clin Drug Investig; 2021 Dec; 41(12):1047-1053. PubMed ID: 34655431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2.
    Anandakrishnan S; Balki M; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2013 Nov; 60(11):1054-60. PubMed ID: 24158878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of prophylactic uterotonics for the third stage of labour after vaginal birth.
    Soltani H; Hutchon DR; Poulose TA
    Cochrane Database Syst Rev; 2010 Aug; (8):CD006173. PubMed ID: 20687079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbetocin at elective caesarean section: a sequential allocation trial to determine the minimum effective dose in obese women.
    Drew T; Balki M; Farine D; Ye XY; Downey K; Carvalho JCA
    Anaesthesia; 2020 Mar; 75(3):331-337. PubMed ID: 31867715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Randomized, Double-blinded Trial of a "Rule of Threes" Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery.
    Kovacheva VP; Soens MA; Tsen LC
    Anesthesiology; 2015 Jul; 123(1):92-100. PubMed ID: 25909969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial.
    Güngördük K; Asicioglu O; Celikkol O; Olgac Y; Ark C
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):36-9. PubMed ID: 20218995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial.
    Sheehan SR; Montgomery AA; Carey M; McAuliffe FM; Eogan M; Gleeson R; Geary M; Murphy DJ;
    BMJ; 2011 Aug; 343():d4661. PubMed ID: 21807773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discontinuing Oxytocin Infusion in the Active Phase of Labor: A Systematic Review and Meta-analysis.
    Saccone G; Ciardulli A; Baxter JK; Quiñones JN; Diven LC; Pinar B; Maruotti GM; Martinelli P; Berghella V
    Obstet Gynecol; 2017 Nov; 130(5):1090-1096. PubMed ID: 29016497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.